MedPath

SPASCUPREEL TABLETS

SPASCUPREEL TABLETS

Discontinued
DIN Number

02029723

Drug Class

Human

Market Date

Dec 31, 1993

Company
HC

Biologische Heilmittel Heel Gmbh

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02029723
AIG Number0953575001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (9)

ACONITEActive
Strength: 6 D
Monograph: ACONITE
AGARICUSActive
Strength: 4 D
Monograph: AGARICUS
ATROPINE SULFATEActive
Strength: 6 D
Monograph: ATROPINE SULFATE
CHAMOMILEActive
Strength: 3 D
Monograph: CHAMOMILE
CITRULLUS COLOCYNTHISActive
Strength: 4 D
Monograph: CITRULLUS COLOCYNTHIS
CUPRIC SULFATEActive
Strength: 6 D
Monograph: CUPRIC SULFATE
GELSEMIUM SEMPERVIRENSActive
Strength: 6 D
Monograph: GELSEMIUM SEMPERVIRENS
MAGNESIUM PHOSPHATE DIBASICActive
Strength: 6 D
Monograph: MAGNESIUM PHOSPHATE DIBASIC
PASSION FLOWERActive
Strength: 2 D
Monograph: PASSION FLOWER

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.